Affordable Access

Publisher Website

Adipose-derived Mesenchymal Stem Cells are Ideal for the Cell-based Treatment of Refractory Wounds: Strong Potential for Angiogenesis.

Authors
  • Cao, Yingxuan1, 2, 3
  • Yan, Jianxin1, 2, 3
  • Dong, Zhiqin1, 2, 3
  • Wang, Jingru4
  • Jiang, Xiao1, 2, 3
  • Cui, Taixing5
  • Huang, Yuesheng6
  • Liu, Hongwei7, 8, 9
  • 1 Department of Plastic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People's Republic of China. , (China)
  • 2 Innovative Technology Research Institute of Plastic Surgery, Guangzhou, 510630, People's Republic of China. , (China)
  • 3 Key Laboratory of Regenerative Medicine, Ministry of Education, Guangzhou, 510632, People's Republic of China. , (China)
  • 4 Department of Burn Surgery, The First People's Hospital of Foshan, Foshan, 528000, China. , (China)
  • 5 Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, MO, 65211, USA. [email protected].
  • 6 Department of Wound Repair, Institute of Wound Repair and Regeneration Medicine, Southern University of Science and Technology Hospital, Southern University of Science and Technology School of Medicine, Shenzhen, 518055, China. [email protected]. , (China)
  • 7 Department of Plastic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People's Republic of China. [email protected]. , (China)
  • 8 Innovative Technology Research Institute of Plastic Surgery, Guangzhou, 510630, People's Republic of China. [email protected]. , (China)
  • 9 Key Laboratory of Regenerative Medicine, Ministry of Education, Guangzhou, 510632, People's Republic of China. [email protected]. , (China)
Type
Published Article
Journal
Stem cell reviews and reports
Publication Date
Jan 01, 2024
Volume
20
Issue
1
Pages
313–328
Identifiers
DOI: 10.1007/s12015-023-10641-y
PMID: 37874529
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Although Mesenchymal Stem Cells (MSCs)-based therapy has been proposed as a promising strategy for the treatment of chronic lower-extremity ulcers, their optimal sources, amounts, and delivery methods are urgently needed to be determined. In this study, we compared the heterogeneity of the human MSCs derived from bone marrow (BMSCs), umbilical cord (UCMSCs), and adipose tissue (ADSCs) in accelerating wound healing and promoting angiogenesis and explored the underlying mechanism. Briefly, a diabetic rat model with a full-thickness cutaneous wound on the dorsal foot was developed. The wound was topically administered with three types of MSCs. Additionally, we carried out in vitro and in vivo analysis of the angiogenic properties of the MSCs. Moreover, the molecular mechanism of the heterogeneity of the MSCs derived from the three tissues was explored by transcriptome sequencing. When compared with the BMSCs- and UCMSCs-treated groups, the ADSCs-treated group exhibited markedly accelerated healing efficiency, characterized by increased wound closure rates, enhanced angiogenesis, and collagen deposition at the wound site. The three types of MSCs formed three-dimensional capillary-like structures and promoted angiogenesis in vitro and in vivo, with ADSCs exhibiting the highest capacity for tube formation and pro-angiogenesis. Furthermore, transcriptome sequencing revealed that ADSCs had higher expression levels of angiogenesis-associated genes. Our findings indicate that MSCs-based therapy accelerates the healing of ischemia- and diabetes-induced lower-extremity ulcers and that adipose tissue-derived MSCs might be ideal for therapeutic angiogenesis and treatment of chronic ischemic wounds. © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Report this publication

Statistics

Seen <100 times